European Ancestry Predominates in Neuromyelitis Optica and Multiple Sclerosis Patients from Brazil
Author(s) -
Doralina Guimarães Brum,
Marcelo R. Luizon,
Antônio Carlos dos Santos,
Marco Aurélio Lana–Peixoto,
Cristiane Franklin Rocha,
Maria Lucia Brito,
Enedina Maria Lobato de Oliveira,
Denis Bernardi Bichuetti,
Alberto A. Gabbai,
Denise Sisterolli Diniz,
Damacio Ramón Kaimen-Maciel,
Elizabeth Regina Comini-Frota,
Cláudia Emília Vieira Wiezel,
Yara Costa Netto Muniz,
Roberta Costa,
Celso Teixeira MendesJunior,
Eduardo Antônio Donadi,
Amilton Antunes Barreira,
Aguinaldo Luíz Simões
Publication year - 2013
Publication title -
plos one
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.99
H-Index - 332
ISSN - 1932-6203
DOI - 10.1371/journal.pone.0058925
Subject(s) - neuromyelitis optica , genetic genealogy , multiple sclerosis , ancestry informative marker , medicine , population , demography , genetic admixture , allele frequency , allele , biology , genetics , immunology , environmental health , gene , sociology
Background Neuromyelitis optica (NMO) is considered relatively more common in non-Whites, whereas multiple sclerosis (MS) presents a high prevalence rate, particularly in Whites from Western countries populations. However, no study has used ancestry informative markers (AIMs) to estimate the genetic ancestry contribution to NMO patients. Methods Twelve AIMs were selected based on the large allele frequency differences among European, African, and Amerindian populations, in order to investigate the genetic contribution of each ancestral group in 236 patients with MS and NMO, diagnosed using the McDonald and Wingerchuck criteria, respectively. All 128 MS patients were recruited at the Faculty of Medicine of Ribeirão Preto (MS-RP), Southeastern Brazil, as well as 108 healthy bone marrow donors considered as healthy controls. A total of 108 NMO patients were recruited from five Neurology centers from different Brazilian regions, including Ribeirão Preto (NMO-RP). Principal Findings European ancestry contribution was higher in MS-RP than in NMO-RP (78.5% vs. 68.7%) patients. In contrast, African ancestry estimates were higher in NMO-RP than in MS-RP (20.5% vs. 12.5%) patients. Moreover, principal component analyses showed that groups of NMO patients from different Brazilian regions were clustered close to the European ancestral population. Conclusions Our findings demonstrate that European genetic contribution predominates in NMO and MS patients from Brazil.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom